Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maculopathy,Age-related”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01272076
What this trial is testing

Cirrus HD-OCT Measurement of Area of Increased Light Penetration Under the Retinal Pigment Epithelium (RPE)

Who this might be right for
Age Related Macular DegenerationGeographic Atrophy
Carl Zeiss Meditec, Inc. 85
Large-scale testing (Phase 3)Study completedNCT04964089
What this trial is testing

Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Kodiak Sciences Inc 557
Large-scale testing (Phase 3)UnknownNCT00260403
What this trial is testing

TTT Versus PDT for Treatment of Choroidal Neovascularization in Age-Related Macular Degeneration

Who this might be right for
Choroidal Neovascularization
St. Erik Eye Hospital 140
Very early researchNot Yet RecruitingNCT07121127
What this trial is testing

Effect of Fu's Subcutaneous Needling for Age-related Macular Degeneration

Who this might be right for
Age - Related Macular Degeneration (AMD)
Zhiming Yan 38
Not applicableNot Yet RecruitingNCT07826286
What this trial is testing

Changes in Intraocular Pressure After Intravitreal Injection

Who this might be right for
Diabetic Macular EdemaNeovascular Age-Related Macular DegenerationRetinal Vein Occlusion+1 more
Assiut University 50
Not applicableWithdrawnNCT03046485
What this trial is testing

Use of Self-management Group to Improve Quality of Life in Patients With Low Vision

Who this might be right for
Age Related Macular Degeneration
Massachusetts Eye and Ear Infirmary
Not applicableStudy completedNCT03714308
What this trial is testing

Aflibercept Injection Into the Vitreous Body of the Eye: Study to Learn More About Patient Relevant Outcomes, Real World Treatment Patterns and How Well the Treatment Works for Patients Suffering From Abnormal Growth of New Blood Vessels Under the Retina.

Who this might be right for
Macular Degeneration
Bayer 554
Not applicableUnknownNCT02871817
What this trial is testing

A Comparison of the Checkup Vision Assessment System to Standard Vision Assessment Tools

Who this might be right for
Age - Related Macular DegenerationDiabetic RetinopathyMetamorphopsia
Digisight Technologies, Inc. 143
Not applicableEnded earlyNCT03133117
What this trial is testing

Deficits, Adaptation and Cerebral Functional Reorganization of Visual Retinotopic Treatments During Normal and Pathological Aging (Age-related Macular Degeneration and Glaucoma)

Who this might be right for
Macular DegenerationGlaucoma
University Hospital, Grenoble 24
Early research (Phase 1)Study completedNCT01691261
What this trial is testing

Implantation of Retinal Pigment Epithelium in Subjects with Acute Wet Age Related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
Moorfields Eye Hospital NHS Foundation Trust 9
Large-scale testing (Phase 3)Study completedNCT00305630
What this trial is testing

Neovascular Age Related Macular Degeneration (AMD), Periocular Corticosteroids, and Photodynamic Therapy (PDT)

Who this might be right for
Choroidal NeovascularizationAge-Related Macular Degeneration
Johns Hopkins University 100
Not applicableStudy completedNCT05066685
What this trial is testing

Characteristics of Patients With Neovascular Age-related Macular Degeneration Enrolled in the Brolucizumab Patient Support Services Program

Who this might be right for
Age-related Macular Degeneration (AMD)
Novartis Pharmaceuticals 18,457
Not applicableActive Not RecruitingNCT06125977
What this trial is testing

Impact of Non-Exudative Type 1 MNV on AMD Progression

Who this might be right for
Age-Related Macular DegenerationNeovascularization, Choroidal
University of Utah 73
Not applicableUnknownNCT03466177
What this trial is testing

Multimodal Retinal Imaging in the Detection and Follow-up of Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseAlzheimer DementiaMild Cognitive Impairment+4 more
Universitaire Ziekenhuizen KU Leuven 320
Not applicableLooking for participantsNCT06843499
What this trial is testing

Effectiveness and Cost-Effectiveness Evaluations of AI-Assisted Diagnostic Software (VeriSee) for Ophthalmic Disease Screening

Who this might be right for
Age-Related Macular Degeneration (AMD)Diabetic Retinopathy (DR)
National Taiwan University Hospital 1,000
Very early researchStudy completedNCT03478865
What this trial is testing

Vitamin A Palmitate Supplementation in People With Age-Related Macular Degeneration (and Without Reticular Pseudodrusen) and Delayed Dark Adaptation

Who this might be right for
AMD
National Eye Institute (NEI) 8
Early research (Phase 1)Study completedNCT00320775
What this trial is testing

Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD

Who this might be right for
Macular Degeneration
Regeneron Pharmaceuticals 51
Post-approval studies (Phase 4)Study completedNCT01986907
What this trial is testing

Safety and Tolerability of Ranibizumab in Mono/Bilateral Wet Age Related Macular Degeneration (w-AMD) Patients in Eyes With BCVA<2/10 and/or 2nd Affected Eye

Who this might be right for
Wet Age Related Macular Degeneration
Novartis Pharmaceuticals 1,049
Early research (Phase 1)Study completedNCT00500344
What this trial is testing

CAPTAIN:Choroidal Neovascularization Assessment by Pattern Electroretinography

Who this might be right for
Age-related Macular Degeneration
Washington University School of Medicine 17
Testing effectiveness (Phase 2)Study completedNCT00511706
What this trial is testing

Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationAge-Related Maculopathy
Allergan 243
Next Page